Methods | Statistics | Clinical | Educational | Industrial | Professional items | World psychology |
Biological: Behavioural genetics · Evolutionary psychology · Neuroanatomy · Neurochemistry · Neuroendocrinology · Neuroscience · Psychoneuroimmunology · Physiological Psychology · Psychopharmacology (Index, Outline)
Morbillivirus measles infection.jpg|
|eMedicine||derm/259 emerg/389 ped/1388|
Measles is a disease caused by a virus, specifically a paramyxovirus of the genus Morbillivirus. Morbilliviruses, like other paramyxoviruses, are enveloped, single-stranded, negative-sense RNA viruses. Symptoms include fever, cough, runny nose, red eyes and a generalized, maculopapular, erythematous rash.
Measles is spread through respiration (contact with fluids from an infected person's nose and mouth, either directly or through aerosol transmission), and is highly contagious—90% of people without immunity sharing a house with an infected person will catch it.The measles is very harmful  Airborne precautionsTemplate:What should be taken for all suspected cases of measles. The incubation period usually lasts for 4–12 days (during which there are, by definition, no symptoms). Infected people remain contagious from the appearance of the first symptoms until 3–5 days after the rash appears.
Symptoms[edit | edit source]
The classical symptoms of measles include a four day fever, the three Cs—cough, coryza (runny nose) and conjunctivitis (red eyes). The fever may reach up to 40° Celsius (104° Fahrenheit). Koplik's spots seen inside the mouth are pathognomonic (diagnostic) for measles but are not often seen, even in real cases of measles, because they are transient and may disappear within a day of arising.
The characteristic measles rash is classically described as a generalized, maculopapular, erythematous rash that begins several days after the fever starts. It starts on the head before spreading to cover most of the body, often causing itching. The rash is said to "stain", changing colour from red to dark brown, before disappearing.[How to reference and link to summary or text]
Diagnosis and treatment[edit | edit source]
Clinical diagnosis of measles requires a history of fever of at least three days together with at least one of the three Cs. Observation of Koplik's spots is also diagnostic of measles.
Alternatively, laboratory diagnosis of measles can be done with confirmation of positive measles IgM antibodies or isolation of measles virus RNA from respiratory specimens. In cases of measles infection following secondary vaccine failure IgM antibody may not be present. However, in the rare case of a secondary vaccine failure, other external symptoms may be present, including nausea, headaches, or a feeling of slight dizziness when turning one's head to the left. In these cases serological confirmation may be made by showing IgG antibody rises by enzyme immunoassay or complement fixation. In children, where phlebotomy is inappropriate, saliva can be collected for salivary measles specific IgA test.[How to reference and link to summary or text] Adults are recommended to seek medical help right away.
Positive contact with other patients known to have measles adds strong epidemiological evidence to the diagnosis. The contact with any infected person in any way, including semen, saliva, or mucus can cause you to get it.
There is no specific treatment or antiviral therapy for uncomplicated measles. Most patients with uncomplicated measles will recover with rest and supportive treatment.
Some patients will develop pneumonia as a sequela to the measles. Histologically, a unique cell can be found in the paracortical region of hyperplastic lymph nodes in patients affected with this condition. This cell, known as the Warthin-Finkeldey cell, is a multinucleated giant with eosinophilic cytoplasmic and nuclear inclusions.[How to reference and link to summary or text]
Transmission[edit | edit source]
The measles is a highly contagious airborne pathogen which spreads primarily via the respiratory system. The virus is transmitted in respiratory secretions, and can be passed from person to person via aerosol droplets containing virus particles, such as those produced by a coughing patient. Once transmission occurs, the virus infects and replicates in the lymphatic system, urinary tract, conjunctivae, blood vessels and central nervous system of its new host. The role of epithelial cells is uncertain, but the virus must infect them to spread to a new individual.
Patients with the measles should be placed on droplet precautions.
Humans are the only known natural hosts of measles, although the virus can infect some non-human primate species.
Complications[edit | edit source]
Complications with measles are relatively common, ranging from relatively mild and less serious diarrhea, to pneumonia and encephalitis (subacute sclerosing panencephalitis), corneal ulceration leading to corneal scarring Complications are usually more severe amongst adults who catch the virus.
The fatality rate from measles for otherwise healthy people in developed countries is low: approximately 1 death per thousand cases.[How to reference and link to summary or text] In underdeveloped nations with high rates of malnutrition and poor healthcare, fatality rates of 10 percent are common.[How to reference and link to summary or text] In immunocompromised patients, the fatality rate is approximately 30 percent.[How to reference and link to summary or text]
Prevention and Public health[edit | edit source]
Measles is a significant infectious disease because, while the rate of complications is not high, the disease itself is so infectious that the sheer number of people who would suffer complications in an outbreak amongst non-immune people would quickly overwhelm available hospital resources. If vaccination rates fall, the number of non-immune persons in the community rises, and the risk of an outbreak of measles consequently rises.
In developed countries, most children are immunized against measles by the age of 18 months, generally as part of a three-part MMR vaccine (measles, mumps, and rubella). The vaccination is generally not given earlier than this because children younger than 18 months usually retain anti-measles immunoglobulins (antibodies) transmitted from the mother during pregnancy. A second dose is usually given to children between the ages of four and five, in order to increase rates of immunity. Vaccination rates have been high enough to make measles relatively uncommon. Even a single case in a college dormitory or similar setting is often met with a local vaccination program, in case any of the people exposed are not already immune.
In developing countries where measles is highly endemic, the WHO recommend that two doses of vaccine be given at six months and at nine months of age. The vaccine should be given whether the child is HIV-infected or not. The vaccine is less effective in HIV-infected infants, but the risk of adverse reactions is low.
Unvaccinated populations are at risk for the disease. After vaccination rates dropped in northern Nigeria in the early 2000s due to religious and political objections, the number of cases rose significantly, and hundreds of children died. A 2005 measles outbreak in Indiana was attributed to children whose parents refused vaccination. In the early 2000s the MMR vaccine controversy in the United Kingdom regarding a potential link between the combined MMR vaccine (vaccinating children from mumps, measles and rubella) and autism prompted a comeback in the measles party, where parents deliberately infect the child with measles to build up the child's immunity without an injection. This practice poses many health risks to the child, and has been discouraged by the public health authorities. Scientific evidence provides no support for the hypothesis that MMR plays a role in causing autism. However, the MMR scare in Britain caused uptake of the vaccine to plunge, and measles cases came back: 2007 saw 971 cases in England and Wales, the biggest rise in occurrence in measles cases since records began in 1995.
According to the World Health Organization (WHO), measles is a leading cause of vaccine preventable childhood mortality. Worldwide, the fatality rate has been significantly reduced by partners in the Measles Initiative: the American Red Cross, the United States Centers for Disease Control and Prevention (CDC), the United Nations Foundation, UNICEF and the World Health Organization (WHO). Globally, measles deaths are down 60 percent, from an estimated 873,000 deaths in 1999 to 345,000 in 2005. Africa has seen the most success, with annual measles deaths falling by 75 percent in just 5 years, from an estimated 506,000 to 126,000.
The joint press release by members of the Measles Initiative brings to light another benefit of the fight against measles: "Measles vaccination campaigns are contributing to the reduction of child deaths from other causes. They have become a channel for the delivery of other life-saving interventions, such as bed nets to protect against malaria, de-worming medicine and vitamin A supplements. Combining measles immunization with other health interventions is a contribution to the achievement of Millennium Development Goal Number 4: a two-thirds reduction in child deaths between 1990 and 2015."
History[edit | edit source]
The first scientific description of measles and its distinction from smallpox and chickenpox is credited to the Persian physician, Muhammad ibn Zakariya ar-Razi (860-932), known to the West as "Rhazes", who published a book entitled The Book of Smallpox and Measles (in Arabic: Kitab fi al-jadari wa-al-hasbah). In roughly the last 150 years, measles has been estimated to have killed about 200 million people worldwide. In 1954, the virus causing the disease was isolated from an 11-year old boy from the United States, David Edmonston, and adapted and propagated on chick embryo tissue culture. To date, 21 strains of the measles virus have been identified. Licensed vaccines to prevent the disease became available in 1963.
Recent outbreaks[edit | edit source]
- Main article: Measles outbreaks in the 2000s
Approximately 1000 cases of the disease were reported in Israel between August 2007 and May 2008 (in sharp contrast to just some dozen cases the year before).[How to reference and link to summary or text] Many children in ultra-Orthodox Jewish communities were affected due to low vaccination coverage. As of 2008 the disease is endemic in the United Kingdom and epidemics have been reported in Austria, Italy and Switzerland. Low vaccination rates are responsible.
The Americas[edit | edit source]
Indigenous measles were declared to have been eliminated in North, Central, and South America; the last endemic case in the region was reported on November 12, 2002. Outbreaks are still occurring, however, following importations of measles viruses from other world regions. In June 2006, an outbreak in Boston resulted after a resident became infected in India, and in October 2007, a Michigan girl who had been vaccinated contracted the disease in Sweden.
Between January 1 and April 25, 2008, a total of 64 confirmed measles cases were preliminarily reported in the United States to the Centers for Disease Control and Prevention, the most reported by this date for any year since 2001. Of the 64 cases, 54 were associated with importation of measles from other countries into the United States, and 63 of the 64 patients were unvaccinated or had unknown or undocumented vaccination status.
By July 9, 2008, a total of 127 cases were reported in 15 states (including 22 in Arizona), making it the largest U.S. outbreak since 1997 (when 138 cases were reported). Most of the cases were acquired outside of the United States and afflicted individuals who had not been vaccinated.
By July 30, 2008, the number of cases had grown to 131. Of these, about half involved children whose parents rejected vaccination. The 131 cases occurred in 7 different outbreaks. There were no deaths, and 15 hospitalizations. 11 of the cases had received at least one dose of the measles vaccine. 122 of the cases involved children who were unvaccinated or whose vaccination status was unknown. Some of these were under the age of one year old, and so below the age when vaccination is recommended, but in 63 cases the vaccinations had been refused for religious or philosophical reasons. Many of the cases involved church groups and the home schooled. 
See also[edit | edit source]
References[edit | edit source]
- New York City Departrment of Health and Mental Hygiene http://www.nyc.gov/html/doh/html/imm/immmea.shtml
- Skalka, Anna M.; Johnson, Flint; Enquist, L. W.; Racaniello, Vincent R. (2003). Principles of Virology: Molecular Biology, Pathogenesis, and Control of Animal Viruses, 2nd ed., American Society Microbiology.
- Leonard VH, Sinn PL, Hodge G, et al (2008). Measles virus blind to its epithelial cell receptor remains virulent in rhesus monkeys but cannot cross the airway epithelium and is not shed. J. Clin. Invest. 118 (7): 2448–2458.
- Helfand RF, Witte D, Fowlkes A, et al. (2008). Evaluation of the immune response to a 2-dose measles vaccination schedule administered at 6 and 9 months of age to HIV-infected and HIV-uninfected children in Malawi. J Infect Dis 198: 1457–1465.
- includeonly>"Measles kills more than 500 children so far in 2005", IRIN, 2005-03-21. Retrieved on 2007-08-13.
- Parker A, Staggs W, Dayan G et al. (2006). Implications of a 2005 measles outbreak in Indiana for sustained elimination of measles in the United States. N Engl J Med 355 (5): 447–55.
- includeonly>Dillner L. "The return of the measles party", Guardian, 2001-07-26. Retrieved on 2007-08-13.
- Rutter M (2005). Incidence of autism spectrum disorders: changes over time and their meaning. Acta Paediatr 94 (1): 2–15.
- Torjesen I (2008-04-17). Disease: a warning from history. Health Serv J: 22–4.
- UNICEF Joint Press Release
- Harminder S. Dua, Ahmad Muneer Otri, Arun D. Singh (2008), "Abu Bakr Razi", British Journal of Ophthalmology (BMJ Group) 92: 1324
- Torrey EF and Yolken RH. 2005. Their bugs are worse than their bite. Washington Post, April 3, p. B01.
- (1980) Live attenuated measles vaccine. EPI Newsl 2 (1): 6.
- Rima BK, Earle JA, Yeo RP, et al (1995). Temporal and geographical distribution of measles virus genotypes. J. Gen. Virol. 76 (5): 1173–80.
- The Public Health Agency of Canada Travel Advisory. URL accessed on 2008-05-02.
- includeonly>Norrie, Justin. "Japanese measles epidemic brings campuses to standstill", The Sydney Morning Herald, May 27, 2007. Retrieved on 2008-07-10.
- Stein-Zamir, C., G. Zentner, N. Abramson, H. Shoob, Y. Aboudy, L. Shulman and E. Mendelson (February 2008). Measles outbreaks affecting children in Jewish ultra-orthodox communities in Jerusalem. Epidemiology and Infection 136 (2): 207–214.
- includeonly>Rotem, Tamar. "Current measles outbreak hit ultra-Orthodox the hardest", Haaretz, August 11, 2007. Retrieved on 2008-07-10.
- Measles outbreak shows a global threat - The Boston Globe. URL accessed on 2007-12-05.
- includeonly>Jesse, David. "Measles outbreak may have spread", The Ann Arbor News, October 4, 2007. Retrieved on 2008-07-10.
- cdc.gov. URL accessed on 2008-05-02.
- JS Online: Measles outbreak brewing, city health officials say
- cdc.gov MeaslesUpdate. URL accessed on 2008-05-02.
- includeonly>Rotstein, Arthur. "Response curtailed measles outbreak", The Associated Press, July 9, 2008. Retrieved on 2008-07-10.
- includeonly>Dunham, Will. "Measles outbreak hits 127 people in 15 states", Reuters, July 9, 2008. Retrieved on 2008-07-10.
- includeonly>Stobbe, Mike. "Jump in U.S. measles cases linked to vaccine fears", The Associated Press, August 21, 2008. Retrieved on 2008-08-21.
[edit | edit source]
- WHO.int - 'Initiative for Vaccine Research (IVR): Measles', World Health Organization (WHO)
- Measles FAQ from Centers for Disease Control and Prevention in the United States
- Case of an adult male with measles (facial photo)
- Clinical pictures of measles
|This page uses Creative Commons Licensed content from Wikipedia (view authors).|